MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Real-life accelerometer-based detection of DBS effects on tremor and dyskinesia in Parkinson’s disease, trained with ecological momentary assessments

    J. Habets, V. Mathiopoulou, L. Drescher, A. Ben Janet, A. Buchwald, L. Muessig, J. Kaplan, A. Memarpouri, J. Vivien, L. Feldmann, G. Brandt, A. Kühn (Berlin, Germany)

    Objective: To detect real-life tremor and dyskinesia fluctuations, using naturalistic wearable data for prediction, and ecological momentary assessments (EMA) data for model training. Background: Parkinson’s…
  • 2026 International Congress

    DTI-ALPS Insights into Glymphatic Dynamics and Neurovascular Changes in Parkinson’s Disease

    G. Yılmaz çakan, A. Bayram, B. Samancı, G. Kızılateş Evin, L. Karşıgil, G. Kenangil, A. Zırh, Y. Samancı (Istanbul, Turkey)

    Objective: To investigate glymphatic activity, structural small vessel disease (SVD) markers, and white matter microstructure in Parkinson’s disease (PD) patients, and to explore their associations…
  • 2026 International Congress

    Metabolic Syndrome is not Associated with Parkinson’s Disease Severity, but Individual Metabolic Components May Be

    TLD. Denicol, MPF. Felippe, GGA. Dal Alba, CMD. Dagostini, JSL. León, AH. Hilbig, CMR. Rieder (Porto Alegre, Brazil)

    Objective: To investigate whether individual metabolic components are associated with motor, cognitive, and functional outcomes in Parkinson’s disease (PD). Background: Metabolic syndrome has been proposed…
  • 2026 International Congress

    Evaluation of Cardiac Markers and Clinical Metrics in Friedreich’s Ataxia

    T. Keller, F. Siddiqui, C. Koehring, T. Zesiewicz, K. Zayas, A. Barrios Gonzalez, K. Kim, T. Mcdonald, A. Patel (Tampa, USA)

    Objective: To evaluate cardiac specific markers and clinical metrics associated with Friedreich’s Ataxia (FA) and FA cardiomyopathy severity and progression. Background: Friedreich’s Ataxia is a…
  • 2026 International Congress

    Multilingual Smartphone Application for Objective Motor Assessment in Parkinson Disease: Cross-Sectional Clinical Validation Study

    B. Biswas, S. Pal, K. Das, D. Santra, D. Mukherjee, R. Gayen, H. Kumar, S. Choudhury (Kolkata, India)

    Objective: To assess the clinical validity of an Android-based application for remote, objective quantification of tremor and hand bradykinesia (2D) in Parkinson’s disease against reference-standard…
  • 2026 International Congress

    The Alternating Finger Tapping Test Poorly Predicts Real-World Daily Activity Performance in Parkinson’s Disease

    P. Kaewsom, K. Horaruengdecha, P. Panyakaew (Bangkok, Thailand)

    Objective: To evaluate hand dexterity and daily hand task performance in individuals with PD and investigate the predictive validity of dexterity testing for functional impairment…
  • 2026 International Congress

    Sleep Patterns and Cognitive Function in Parkinson’s Disease: a Longitudinal Pilot Study

    ML. Nasi, E. Fiorenzato, L. Rigon, F. Vianello, D. Lupi, L. Weis, N. Cellini, A. Antonini, R. Biundo (Padova, Italy)

    Objective: To evaluate the feasibility and usability of a commercially available wearable device for long-term monitoring of sleep patterns in Parkinson’s disease (PD) and how…
  • 2026 International Congress

    MLR–cerebellar network in body-first vs. brain-first PD: functional connectivity and clinical correlation with gait impairment

    J. Jin, Z. Zong, S. Si, S. She, W. Wang, P. Pan (Wuhan, China)

    Objective: This study aims to clarify subtype-specific changes in mesencephalic locomotor region (MLR)-cerebellar functional connectivity(FC)[1][2] between body-first and brain-first Parkinson’s disease (PD) patients[3][4], and to further characterize…
  • 2026 International Congress

    Simultaneous EEG and Pallidal Local Field Potential Recording in the Diagnosis of Paroxysmal Movements in a Patient with PDE2A Mutation

    S. Yarlagadda, E. Gleichgerrcht, C. Buetefisch (Atlanta, USA)

    Objective: To describe the diagnostic value of pallidal local field potentials in distinguishing movement disorder from seizure in a complex phenotype. Background: Sensing-capable deep brain…
  • 2026 International Congress

    Safer AI Dosing Recommendations in Parkinson’s Disease Through Uncertainty-Adaptive Prediction

    R. Diaz-Rincon, L. Liang, A. Ramirez-Zamora, B. Shickel (Gainesville, USA)

    Objective: To develop and validate a uncertainty-adaptive AI framework to improve the safety and clinical utility of levodopa dose predictions by explicitly flagging high-risk, ambiguous cases…
  • « Previous Page
  • 1
  • …
  • 164
  • 165
  • 166
  • 167
  • 168
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley